Approval · Notice of Compliance 23725 · 2020
SUPREFACT: Notice of Compliance 23725
Issued June 4, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23725
- Date
- June 4, 2020
- Company
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in Product Ownership
Products in this notice
Medicinal ingredients
- BUSERELIN ACETATE 1 MG per ML